Workflow
Hims & Hers Health, Inc. (HIMS) Stock Sinks As Market Gains: Here's Why
HimsHims(US:HIMS) ZACKSยท2025-09-15 22:46

Core Insights - Hims & Hers Health, Inc. (HIMS) stock closed at $54.03, down 2.65% from the previous day, underperforming the S&P 500's gain of 0.47% [1] - The stock has increased by 20.6% over the past month, outperforming the Medical sector's gain of 5.49% and the S&P 500's gain of 2.32% [1] Financial Performance Expectations - Analysts expect Hims & Hers to report earnings of $0.09 per share, reflecting a year-over-year growth of 50% [2] - Revenue is forecasted to be $581.61 million, indicating a 44.84% growth compared to the same quarter last year [2] - For the full year, earnings are expected to be $0.6 per share and revenue at $2.35 billion, representing increases of 122.22% and 58.91% respectively from the previous year [3] Analyst Estimates and Market Sentiment - Recent changes in analyst estimates for Hims & Hers are important as they reflect short-term business trends, with positive revisions indicating optimism [4] - The Zacks Rank system, which evaluates estimate changes, currently ranks Hims & Hers at 3 (Hold), with a recent downward shift of 6.27% in the consensus EPS estimate [6] Valuation Metrics - Hims & Hers has a Forward P/E ratio of 92.79, significantly higher than the industry average of 33.15, indicating a premium valuation [7] - The company also has a PEG ratio of 3.75, compared to the industry average of 3.36, suggesting a higher expected earnings growth trajectory [8] Industry Context - The Medical Info Systems industry, which includes Hims & Hers, has a Zacks Industry Rank of 74, placing it in the top 30% of over 250 industries [8] - The Zacks Industry Rank measures the strength of industry groups, with top-rated industries outperforming lower-rated ones by a factor of 2 to 1 [9]